The Liver Meeting 2024 Research: NASH-CHECK Presentation by Arun J. Sanyal, MBBS, MD

Co-chair of the TARGET-NASH steering committee, Arun J. Sanyal, MBBS, MD, helped author a new Target RWE study which was presented at The Liver Meeting 2024 titled, “Stability of the NASH-CHECK patient-reported outcome measure over time in patients with metabolic dysfunction-associated steatotic liver disease and stable clinical status.”

This study explores the stability of the NASH-CHECK patient-reported outcome measure in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). Using data from the TARGET-NASH cohort, we investigate the reliability and consistency of the NASH-CHECK scores over time, even in patients with stable disease. Watch the video presentation by Dr. Sanyal.